Research

  • Isomorphic Labs nears first trials of AI drugs

    Alphabet’s drug discovery unit Isomorphic Labs is preparing to test its AI-designed medicines in humans for the first time, its president has confirmed. Colin Murdoch, president of Isomorphic Labs and chief business officer at Google DeepMind, said clinical trials were "very close" following years of development. Murdoch told Fortune during an interview in Paris: “There [...]

  • Scientists find new drug targets for tuberculosis

    Scientists have identified two new families of drug molecules that could lead to future treatments for tuberculosis, the world’s second deadliest infectious disease after Covid-19. The compounds work by blocking an enzyme that tuberculosis bacteria use to convert cholesterol into energy, offering a potential way to starve the bacteria and combat the disease, which causes [...]

  • Synthetic DNA project raises medical hopes and ethical fears

    Scientists are creating synthetic human DNA from scratch in a contentious project that could lead to new treatments for major illnesses. The research focuses on using lab-built DNA sections to develop therapies for autoimmune disorders, heart failure, viral infections and age-related diseases. These synthetic DNA strands are being inserted into skin cells to observe how [...]

  • Portable device could make personalised medicines in hospitals

    A new portable gene therapy device could allow hospital pharmacies to create personalised medicines on demand for rare disease patients, a new study suggests. The technology could reduce reliance on centralised drug manufacturing by enabling pharmacists to prepare treatments directly at the bedside. This approach may address the challenge of treating rare diseases, which affect [...]

  • Galway to host €34m healthtech commercialisation hub

    A new €34.3m research centre based at University of Galway will focus on developing healthcare technologies for chronic disease management and supporting their commercialisation in Ireland’s north and west. The Accelerating Research to Commercialisation (ARC) Hub for Healthtech will develop smart implants — devices placed inside the body to monitor or treat medical conditions — [...]

  • Virtual therapy dogs ease stress through short videos

    A short video session with a therapy dog can significantly reduce stress levels, according to new research comparing virtual interventions with in-person interactions. The study found that five-minute pre-recorded sessions featuring therapy dogs helped ease stress among both students and members of the public, highlighting the value of virtual alternatives for people unable to access [...]

  • Genetic study launched after weight loss jab deaths

    A genetic study has been launched following hundreds of reported pancreatitis cases linked to weight loss and diabetes jabs, including ten deaths. Researchers will examine whether genetic differences influence the risk of developing pancreatitis — inflammation of the pancreas — in people taking GLP-1 medicines. These drugs mimic a natural hormone that helps regulate blood [...]

  • Exeter biotech partners with L’Oréal on ageing research

    An Exeter-based biotech company has partnered with L'Oréal to explore new ways of reversing the ageing process at the cellular level. SENISCA, a spinout from the University of Exeter, will collaborate with L'Oréal under a newly announced research agreement targeting senescent cells — older cells that no longer function properly but remain active in the [...]

  • UK joins new global AI healthcare network

    The UK has become the first country to join a new international network of health regulators focused on the safe and effective use of AI in healthcare. The Medicines and Healthcare products Regulatory Agency (MHRA) joined the HealthAI Global Regulatory Network on 24 June as a founding ‘pioneer’ member, placing the UK at the centre [...]

  • Doctors stop using bedside ultrasound despite training

    Many doctors stop using point-of-care ultrasound (POCUS) shortly after training due to workplace barriers that prevent it from becoming routine, new research suggests. POCUS devices allow rapid bedside imaging and can identify conditions such as heart failure, fluid in the lungs, and internal bleeding — all of which may be treatable if caught early. Although [...]